Bemosubaiabimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bemosubaiabimab, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer [Phase 2]